CD4 and COVID-19: Additional studies in a small number of individuals suggested that pre-existing CD4+ and CD8+ T cells against alpha common cold coronavirus (229E) but no other seasonal coronaviruses were associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients [49].